EUVIMEDEUVIMED entdecken
Crossref

Pyrrolidine‐2‐carbonitrile Derivatives as Multifunctional Antidiabetic Agents: Inhibition of α ‐Amylase, α ‐Glucosidase, and DPP‐IV With Structure‐Activity Relationships, HSA Binding, and Molecular Docking Studies

Aeyaz Ahmad Bhat, Iqubal Singh iD

Drug Development Research · 2025

DOI: 10.1002/ddr.70170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Aeyaz Ahmad Bhat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, India. Hauptthemen laut MEDLINE: Hypoglycemic Agents, alpha-Amylases, Glycoside Hydrolase Inhibitors, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of pyrrolidine‐2‐carbonitrile derivatives was designed, synthesized, and evaluated for their antidiabetic potential. The synthesized compounds exhibited notable inhibitory activity, with IC₅₀ values ranging from 9.36 to 21.54 µg/mL for α ‐amylase, 13.32 to 46.14 µg/mL for α ‐glucosidase, and 22.87 to 42.12 µg/mL for DPP‐IV. Among the evaluated derivatives, compounds bearing para‐methyl ( 6b ) and para‐chloro ( 6c ) substituents demonstrated the most potent inhibitory activity across all three enzymatic targets. To elucidate the underlying trends, a SAR analysis was conducted, revealing that both electronic properties and steric effects of the substituents significantly influenced enzyme inhibition potency. The molecular docking studies showed strong and specific interactions between the active compounds and key residues within the catalytic sites of the target enzymes. In addition, UV‐visible absorption and fluorescence spectroscopy studies demonstrated high binding affinities for both 6b and 6c with HSA, having binding constant (K a ) values of 7.31 × 10⁵ M⁻¹ and 7.43 × 10⁵ M⁻¹, respectively. Taken together, these findings highlight compounds 6b and 6c as promising lead candidates for the development of multitarget antidiabetic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic Agentsalpha-AmylasesGlycoside Hydrolase InhibitorsDipeptidyl-Peptidase IV InhibitorsPyrrolidinesNitrilesMolecular Docking SimulationStructure-Activity Relationshipalpha-GlucosidasesHumansDipeptidyl Peptidase 4Protein Binding

Stichwörter der Autor:innen

DPP‐IVantidiabetic agentspyrrolidine‐2‐carbonitrilestructure‐activity relationshipα‐Amylaseα‐Glucosidase

Substanzen

Hypoglycemic Agentsalpha-Amylasesalpha-GlucosidasesGlycoside Hydrolase InhibitorsDipeptidyl-Peptidase IV InhibitorsPyrrolidinesDipeptidyl Peptidase 4Nitriles

Autor:innen und Institutionen

  • Department of Chemistry, School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, India.
  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.

ORCID-Profile: Iqubal Singh

Zitieren

APA

Bhat, A. A., & Singh, I. (2025). Pyrrolidine‐2‐carbonitrile Derivatives as Multifunctional Antidiabetic Agents: Inhibition of α ‐Amylase, α ‐Glucosidase, and DPP‐IV With Structure‐Activity Relationships, HSA Binding, and Molecular Docking Studies. Drug Development Research. https://doi.org/10.1002/ddr.70170

Vancouver

Bhat AA, Singh I. Pyrrolidine‐2‐carbonitrile Derivatives as Multifunctional Antidiabetic Agents: Inhibition of α ‐Amylase, α ‐Glucosidase, and DPP‐IV With Structure‐Activity Relationships, HSA Binding, and Molecular Docking Studies. Drug Development Research. 2025. doi:10.1002/ddr.70170

BibTeX
@article{Bhat2025,
  author = {Bhat, Aeyaz Ahmad and Singh, Iqubal},
  title = {Pyrrolidine‐2‐carbonitrile Derivatives as Multifunctional Antidiabetic Agents: Inhibition of α ‐Amylase, α ‐Glucosidase, and DPP‐IV With Structure‐Activity Relationships, HSA Binding, and Molecular Docking Studies},
  journal = {Drug Development Research},
  year = {2025},
  doi = {10.1002/ddr.70170}
}
Kostenlos starten →